ST7: A Potential Drug Target and Biomarker (G7982)

Target Name: ST7

NCBI ID: G7982

Content of Review Report on ST7 Target / Biomarker

ST7

ST7: A Potential Drug Target and Biomarker

Stanford University School of Medicine, Stanford, California

Stanford University School of Medicine, Stanford, California

Stanford ST7 database

The Stanford ST7 database is a collection of RNA transcripts, including gene expression data, for the ST7 gene family. The ST7 gene family is part of the uncontained non-coding RNA (ncRNA) gene family, which has been identified in various organisms as key regulators of gene expression and development.

Targeting ST7: A novel drug target

The ST7 gene family has been implicated in a wide range of physiological processes, including cell signaling, metabolism, and stress response. Several studies have identified ST7 as a potential drug target, due to its involvement in various cellular processes that are crucial for human health and disease.

One of the key reasons for targeting ST7 is its involvement in the regulation of cell signaling pathways. The ST7 gene is known to be involved in the regulation of several signaling pathways, including the TGF-β pathway, the PI3K/Akt pathway, and the NF-kappa-B pathway. These pathways are involved in various cellular processes that are crucial for normal development, wound healing, and stress response.

In addition to its role in cell signaling, ST7 is also known to be involved in the regulation of cellular metabolism. The ST7 gene has been shown to be involved in the regulation of cellular metabolism, including the metabolism of nutrients and the detoxification of harmful substances.

Targeting ST7: A potential biomarker

The ST7 gene is also a potential biomarker for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. This is because the ST7 gene is involved in the regulation of various cellular processes that are involved in the development and progression of these diseases.

For example, several studies have shown that ST7 is involved in the regulation of the development and progression of cancer. In addition, the ST7 gene has been shown to be involved in the regulation of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.

In addition to its involvement in cancer and neurodegenerative diseases, ST7 is also involved in the regulation of autoimmune diseases. The ST7 gene has been shown to be involved in the regulation of the immune response, including the regulation of T cell function.

Conclusion

In conclusion, the ST7 gene family has been shown to be involved in a wide range of cellular processes that are crucial for human health and disease. As a result, targeting ST7 has the potential to lead to new therapeutic approaches for a variety of diseases. The Stanford ST7 database is a valuable resource for the study of the ST7 gene and its role in various cellular processes. Further research is needed to fully understand the implications of ST7 as a drug target and biomarker.

Protein Name: Suppression Of Tumorigenicity 7

Functions: May act as a tumor suppressor

The "ST7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ST7 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets